nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenazopyridine—Haemolytic anaemia—Erlotinib—kidney cancer	0.00526	0.0266	CcSEcCtD
Phenazopyridine—Jaundice—Pazopanib—kidney cancer	0.00468	0.0237	CcSEcCtD
Phenazopyridine—Jaundice—Everolimus—kidney cancer	0.0037	0.0187	CcSEcCtD
Phenazopyridine—Hepatitis—Everolimus—kidney cancer	0.0034	0.0172	CcSEcCtD
Phenazopyridine—Hepatitis—Erlotinib—kidney cancer	0.00329	0.0166	CcSEcCtD
Phenazopyridine—Jaundice—Sorafenib—kidney cancer	0.00321	0.0162	CcSEcCtD
Phenazopyridine—Visual disturbance—Paclitaxel—kidney cancer	0.00291	0.0147	CcSEcCtD
Phenazopyridine—Hepatitis—Sunitinib—kidney cancer	0.00284	0.0144	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.00281	0.0142	CcSEcCtD
Phenazopyridine—Dyspepsia—Pazopanib—kidney cancer	0.0027	0.0136	CcSEcCtD
Phenazopyridine—Hepatitis—Dactinomycin—kidney cancer	0.00269	0.0136	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Pazopanib—kidney cancer	0.00264	0.0134	CcSEcCtD
Phenazopyridine—Haemolytic anaemia—Capecitabine—kidney cancer	0.00251	0.0127	CcSEcCtD
Phenazopyridine—Hypersensitivity—Temsirolimus—kidney cancer	0.0024	0.0121	CcSEcCtD
Phenazopyridine—Pruritus—Temsirolimus—kidney cancer	0.0023	0.0116	CcSEcCtD
Phenazopyridine—Diarrhoea—Temsirolimus—kidney cancer	0.00222	0.0112	CcSEcCtD
Phenazopyridine—Pruritus—Pazopanib—kidney cancer	0.00217	0.0109	CcSEcCtD
Phenazopyridine—Dyspepsia—Everolimus—kidney cancer	0.00213	0.0108	CcSEcCtD
Phenazopyridine—Diarrhoea—Pazopanib—kidney cancer	0.0021	0.0106	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Everolimus—kidney cancer	0.00209	0.0105	CcSEcCtD
Phenazopyridine—Vomiting—Temsirolimus—kidney cancer	0.00207	0.0104	CcSEcCtD
Phenazopyridine—Dyspepsia—Erlotinib—kidney cancer	0.00205	0.0104	CcSEcCtD
Phenazopyridine—Rash—Temsirolimus—kidney cancer	0.00205	0.0104	CcSEcCtD
Phenazopyridine—Dermatitis—Temsirolimus—kidney cancer	0.00205	0.0103	CcSEcCtD
Phenazopyridine—Headache—Temsirolimus—kidney cancer	0.00204	0.0103	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00201	0.0102	CcSEcCtD
Phenazopyridine—Vomiting—Pazopanib—kidney cancer	0.00195	0.00984	CcSEcCtD
Phenazopyridine—Rash—Pazopanib—kidney cancer	0.00193	0.00976	CcSEcCtD
Phenazopyridine—Nausea—Temsirolimus—kidney cancer	0.00193	0.00976	CcSEcCtD
Phenazopyridine—Dermatitis—Pazopanib—kidney cancer	0.00193	0.00975	CcSEcCtD
Phenazopyridine—Headache—Pazopanib—kidney cancer	0.00192	0.0097	CcSEcCtD
Phenazopyridine—Dyspepsia—Sorafenib—kidney cancer	0.00185	0.00934	CcSEcCtD
Phenazopyridine—Visual impairment—Paclitaxel—kidney cancer	0.00184	0.0093	CcSEcCtD
Phenazopyridine—Nausea—Pazopanib—kidney cancer	0.00182	0.00919	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00181	0.00916	CcSEcCtD
Phenazopyridine—Hypersensitivity—Vinblastine—kidney cancer	0.00179	0.00904	CcSEcCtD
Phenazopyridine—Hypersensitivity—Everolimus—kidney cancer	0.00178	0.009	CcSEcCtD
Phenazopyridine—Dyspepsia—Sunitinib—kidney cancer	0.00178	0.00898	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00174	0.00881	CcSEcCtD
Phenazopyridine—Pruritus—Everolimus—kidney cancer	0.00171	0.00865	CcSEcCtD
Phenazopyridine—Jaundice—Capecitabine—kidney cancer	0.0017	0.0086	CcSEcCtD
Phenazopyridine—Diarrhoea—Vinblastine—kidney cancer	0.00166	0.00839	CcSEcCtD
Phenazopyridine—Diarrhoea—Everolimus—kidney cancer	0.00166	0.00836	CcSEcCtD
Phenazopyridine—Pruritus—Erlotinib—kidney cancer	0.00165	0.00834	CcSEcCtD
Phenazopyridine—Diarrhoea—Erlotinib—kidney cancer	0.0016	0.00807	CcSEcCtD
Phenazopyridine—Hepatitis—Capecitabine—kidney cancer	0.00157	0.00792	CcSEcCtD
Phenazopyridine—Hypersensitivity—Sorafenib—kidney cancer	0.00155	0.00781	CcSEcCtD
Phenazopyridine—Vomiting—Vinblastine—kidney cancer	0.00154	0.0078	CcSEcCtD
Phenazopyridine—Vomiting—Everolimus—kidney cancer	0.00154	0.00777	CcSEcCtD
Phenazopyridine—Rash—Everolimus—kidney cancer	0.00153	0.0077	CcSEcCtD
Phenazopyridine—Dermatitis—Everolimus—kidney cancer	0.00152	0.0077	CcSEcCtD
Phenazopyridine—Headache—Vinblastine—kidney cancer	0.00152	0.00768	CcSEcCtD
Phenazopyridine—Headache—Everolimus—kidney cancer	0.00152	0.00766	CcSEcCtD
Phenazopyridine—Visual impairment—Capecitabine—kidney cancer	0.00151	0.00763	CcSEcCtD
Phenazopyridine—Hypersensitivity—Sunitinib—kidney cancer	0.00149	0.00752	CcSEcCtD
Phenazopyridine—Pruritus—Sorafenib—kidney cancer	0.00149	0.0075	CcSEcCtD
Phenazopyridine—Vomiting—Erlotinib—kidney cancer	0.00148	0.0075	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Vincristine—kidney cancer	0.00148	0.00745	CcSEcCtD
Phenazopyridine—Rash—Erlotinib—kidney cancer	0.00147	0.00743	CcSEcCtD
Phenazopyridine—Dermatitis—Erlotinib—kidney cancer	0.00147	0.00743	CcSEcCtD
Phenazopyridine—Headache—Erlotinib—kidney cancer	0.00146	0.00739	CcSEcCtD
Phenazopyridine—Nausea—Vinblastine—kidney cancer	0.00144	0.00729	CcSEcCtD
Phenazopyridine—Nausea—Everolimus—kidney cancer	0.00144	0.00726	CcSEcCtD
Phenazopyridine—Diarrhoea—Sorafenib—kidney cancer	0.00144	0.00726	CcSEcCtD
Phenazopyridine—Pruritus—Sunitinib—kidney cancer	0.00143	0.00722	CcSEcCtD
Phenazopyridine—Hypersensitivity—Dactinomycin—kidney cancer	0.00141	0.00712	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.0014	0.00707	CcSEcCtD
Phenazopyridine—Nausea—Erlotinib—kidney cancer	0.00139	0.007	CcSEcCtD
Phenazopyridine—Diarrhoea—Sunitinib—kidney cancer	0.00138	0.00698	CcSEcCtD
Phenazopyridine—Vomiting—Sorafenib—kidney cancer	0.00134	0.00674	CcSEcCtD
Phenazopyridine—Rash—Sorafenib—kidney cancer	0.00132	0.00669	CcSEcCtD
Phenazopyridine—Dermatitis—Sorafenib—kidney cancer	0.00132	0.00668	CcSEcCtD
Phenazopyridine—Headache—Sorafenib—kidney cancer	0.00132	0.00664	CcSEcCtD
Phenazopyridine—Diarrhoea—Dactinomycin—kidney cancer	0.00131	0.00661	CcSEcCtD
Phenazopyridine—Vomiting—Sunitinib—kidney cancer	0.00128	0.00649	CcSEcCtD
Phenazopyridine—Rash—Sunitinib—kidney cancer	0.00127	0.00644	CcSEcCtD
Phenazopyridine—Dermatitis—Sunitinib—kidney cancer	0.00127	0.00643	CcSEcCtD
Phenazopyridine—Headache—Sunitinib—kidney cancer	0.00127	0.00639	CcSEcCtD
Phenazopyridine—Hypersensitivity—Vincristine—kidney cancer	0.00126	0.00636	CcSEcCtD
Phenazopyridine—Nausea—Sorafenib—kidney cancer	0.00125	0.0063	CcSEcCtD
Phenazopyridine—Vomiting—Dactinomycin—kidney cancer	0.00122	0.00614	CcSEcCtD
Phenazopyridine—Rash—Dactinomycin—kidney cancer	0.00121	0.00609	CcSEcCtD
Phenazopyridine—Nausea—Sunitinib—kidney cancer	0.0012	0.00606	CcSEcCtD
Phenazopyridine—Dyspepsia—Paclitaxel—kidney cancer	0.00119	0.00604	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00117	0.00592	CcSEcCtD
Phenazopyridine—Diarrhoea—Vincristine—kidney cancer	0.00117	0.00591	CcSEcCtD
Phenazopyridine—Pruritus—Gemcitabine—kidney cancer	0.00115	0.00579	CcSEcCtD
Phenazopyridine—Nausea—Dactinomycin—kidney cancer	0.00114	0.00574	CcSEcCtD
Phenazopyridine—Diarrhoea—Gemcitabine—kidney cancer	0.00111	0.0056	CcSEcCtD
Phenazopyridine—Jaundice—Doxorubicin—kidney cancer	0.0011	0.00554	CcSEcCtD
Phenazopyridine—SCN9A—Developmental Biology—HNF1B—kidney cancer	0.00109	0.00136	CbGpPWpGaD
Phenazopyridine—Vomiting—Vincristine—kidney cancer	0.00109	0.00549	CcSEcCtD
Phenazopyridine—Rash—Vincristine—kidney cancer	0.00108	0.00544	CcSEcCtD
Phenazopyridine—Dermatitis—Vincristine—kidney cancer	0.00108	0.00544	CcSEcCtD
Phenazopyridine—Headache—Vincristine—kidney cancer	0.00107	0.00541	CcSEcCtD
Phenazopyridine—SCN11A—Developmental Biology—CTNNA1—kidney cancer	0.00105	0.00131	CbGpPWpGaD
Phenazopyridine—SCN11A—L1CAM interactions—MAPK3—kidney cancer	0.00105	0.00131	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—SPTBN4—kidney cancer	0.00105	0.00131	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—L1CAM—kidney cancer	0.00105	0.00131	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—HNF1B—kidney cancer	0.00104	0.0013	CbGpPWpGaD
Phenazopyridine—Vomiting—Gemcitabine—kidney cancer	0.00103	0.00521	CcSEcCtD
Phenazopyridine—Rash—Gemcitabine—kidney cancer	0.00102	0.00516	CcSEcCtD
Phenazopyridine—Dermatitis—Gemcitabine—kidney cancer	0.00102	0.00516	CcSEcCtD
Phenazopyridine—Headache—Gemcitabine—kidney cancer	0.00102	0.00513	CcSEcCtD
Phenazopyridine—Nausea—Vincristine—kidney cancer	0.00102	0.00513	CcSEcCtD
Phenazopyridine—Hepatitis—Doxorubicin—kidney cancer	0.00101	0.00511	CcSEcCtD
Phenazopyridine—SCN11A—Developmental Biology—PAX6—kidney cancer	0.00101	0.00126	CbGpPWpGaD
Phenazopyridine—SCN11A—L1CAM interactions—MAPK1—kidney cancer	0.001	0.00125	CbGpPWpGaD
Phenazopyridine—Hypersensitivity—Paclitaxel—kidney cancer	0.001	0.00505	CcSEcCtD
Phenazopyridine—SCN4A—Developmental Biology—HNF1B—kidney cancer	0.000999	0.00125	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—HNF1B—kidney cancer	0.000999	0.00125	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—PAK1—kidney cancer	0.000981	0.00122	CbGpPWpGaD
Phenazopyridine—Dyspepsia—Capecitabine—kidney cancer	0.00098	0.00495	CcSEcCtD
Phenazopyridine—Visual impairment—Doxorubicin—kidney cancer	0.000974	0.00492	CcSEcCtD
Phenazopyridine—SCN10A—Developmental Biology—HNF1B—kidney cancer	0.000963	0.0012	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—HNF1B—kidney cancer	0.000963	0.0012	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—CTNNA1—kidney cancer	0.000963	0.0012	CbGpPWpGaD
Phenazopyridine—Nausea—Gemcitabine—kidney cancer	0.000963	0.00486	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000962	0.00486	CcSEcCtD
Phenazopyridine—SCN8A—L1CAM interactions—MAPK3—kidney cancer	0.000962	0.0012	CbGpPWpGaD
Phenazopyridine—Pruritus—Paclitaxel—kidney cancer	0.00096	0.00485	CcSEcCtD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000947	0.00118	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Paclitaxel—kidney cancer	0.000929	0.00469	CcSEcCtD
Phenazopyridine—SCN8A—Developmental Biology—PAX6—kidney cancer	0.000922	0.00115	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CER1—kidney cancer	0.000919	0.00115	CbGpPWpGaD
Phenazopyridine—SCN8A—L1CAM interactions—MAPK1—kidney cancer	0.000915	0.00114	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—PAK1—kidney cancer	0.000906	0.00113	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—PAK1—kidney cancer	0.000874	0.00109	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—PAK1—kidney cancer	0.000867	0.00108	CbGpPWpGaD
Phenazopyridine—Vomiting—Paclitaxel—kidney cancer	0.000863	0.00436	CcSEcCtD
Phenazopyridine—Rash—Paclitaxel—kidney cancer	0.000856	0.00432	CcSEcCtD
Phenazopyridine—SCN7A—Axon guidance—KDR—kidney cancer	0.000855	0.00107	CbGpPWpGaD
Phenazopyridine—Dermatitis—Paclitaxel—kidney cancer	0.000855	0.00432	CcSEcCtD
Phenazopyridine—Headache—Paclitaxel—kidney cancer	0.00085	0.0043	CcSEcCtD
Phenazopyridine—SCN7A—Axon guidance—MET—kidney cancer	0.000837	0.00104	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—PAK1—kidney cancer	0.000833	0.00104	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—PAK1—kidney cancer	0.000833	0.00104	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—EPAS1—kidney cancer	0.000831	0.00104	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—HNF1A—kidney cancer	0.000831	0.00104	CbGpPWpGaD
Phenazopyridine—Hypersensitivity—Capecitabine—kidney cancer	0.000821	0.00415	CcSEcCtD
Phenazopyridine—Nausea—Paclitaxel—kidney cancer	0.000806	0.00407	CcSEcCtD
Phenazopyridine—SCN1A—Axon guidance—PAK1—kidney cancer	0.000803	0.001	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—PAK1—kidney cancer	0.000803	0.001	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—PAK1—kidney cancer	0.0008	0.000997	CbGpPWpGaD
Phenazopyridine—Pruritus—Capecitabine—kidney cancer	0.000788	0.00398	CcSEcCtD
Phenazopyridine—SCN9A—Developmental Biology—CTNNA1—kidney cancer	0.000779	0.000972	CbGpPWpGaD
Phenazopyridine—SCN9A—L1CAM interactions—MAPK3—kidney cancer	0.000778	0.00097	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—KDR—kidney cancer	0.000762	0.000951	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Capecitabine—kidney cancer	0.000762	0.00385	CcSEcCtD
Phenazopyridine—SCN11A—Axon guidance—MET—kidney cancer	0.000746	0.00093	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—PAX6—kidney cancer	0.000746	0.00093	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—CTNNA1—kidney cancer	0.000745	0.000929	CbGpPWpGaD
Phenazopyridine—SCN3A—L1CAM interactions—MAPK3—kidney cancer	0.000744	0.000927	CbGpPWpGaD
Phenazopyridine—SCN9A—L1CAM interactions—MAPK1—kidney cancer	0.00074	0.000923	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—CTNNA1—kidney cancer	0.000716	0.000893	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—CTNNA1—kidney cancer	0.000716	0.000893	CbGpPWpGaD
Phenazopyridine—SCN2A—L1CAM interactions—MAPK3—kidney cancer	0.000715	0.000891	CbGpPWpGaD
Phenazopyridine—SCN4A—L1CAM interactions—MAPK3—kidney cancer	0.000715	0.000891	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—PAX6—kidney cancer	0.000713	0.000889	CbGpPWpGaD
Phenazopyridine—Vomiting—Capecitabine—kidney cancer	0.000708	0.00358	CcSEcCtD
Phenazopyridine—SCN3A—L1CAM interactions—MAPK1—kidney cancer	0.000708	0.000882	CbGpPWpGaD
Phenazopyridine—Rash—Capecitabine—kidney cancer	0.000702	0.00355	CcSEcCtD
Phenazopyridine—Dermatitis—Capecitabine—kidney cancer	0.000702	0.00354	CcSEcCtD
Phenazopyridine—Headache—Capecitabine—kidney cancer	0.000698	0.00353	CcSEcCtD
Phenazopyridine—SCN8A—Axon guidance—KDR—kidney cancer	0.000697	0.000869	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—CTNNA1—kidney cancer	0.00069	0.000861	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—CTNNA1—kidney cancer	0.00069	0.000861	CbGpPWpGaD
Phenazopyridine—SCN10A—L1CAM interactions—MAPK3—kidney cancer	0.000689	0.000859	CbGpPWpGaD
Phenazopyridine—SCN1A—L1CAM interactions—MAPK3—kidney cancer	0.000689	0.000859	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—PAX6—kidney cancer	0.000685	0.000854	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—PAX6—kidney cancer	0.000685	0.000854	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—MET—kidney cancer	0.000682	0.000851	CbGpPWpGaD
Phenazopyridine—SCN2A—L1CAM interactions—MAPK1—kidney cancer	0.00068	0.000848	CbGpPWpGaD
Phenazopyridine—SCN4A—L1CAM interactions—MAPK1—kidney cancer	0.00068	0.000848	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—HNF1B—kidney cancer	0.000677	0.000845	CbGpPWpGaD
Phenazopyridine—Nausea—Capecitabine—kidney cancer	0.000662	0.00334	CcSEcCtD
Phenazopyridine—SCN1A—Developmental Biology—PAX6—kidney cancer	0.000661	0.000824	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—PAX6—kidney cancer	0.000661	0.000824	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000659	0.000822	CbGpPWpGaD
Phenazopyridine—SCN1A—L1CAM interactions—MAPK1—kidney cancer	0.000656	0.000818	CbGpPWpGaD
Phenazopyridine—SCN10A—L1CAM interactions—MAPK1—kidney cancer	0.000656	0.000818	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—PAK1—kidney cancer	0.000647	0.000806	CbGpPWpGaD
Phenazopyridine—Dyspepsia—Doxorubicin—kidney cancer	0.000632	0.00319	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.00062	0.00313	CcSEcCtD
Phenazopyridine—SCN3A—Developmental Biology—PAK1—kidney cancer	0.000618	0.000771	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—RAF1—kidney cancer	0.000618	0.000771	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—ERBB2—kidney cancer	0.000612	0.000763	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—KDR—kidney cancer	0.00061	0.000761	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—MET—kidney cancer	0.000597	0.000745	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—PAK1—kidney cancer	0.000594	0.000741	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—PAK1—kidney cancer	0.000594	0.000741	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—PAK1—kidney cancer	0.000573	0.000714	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—PAK1—kidney cancer	0.000573	0.000714	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—PAK1—kidney cancer	0.000564	0.000704	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—KDR—kidney cancer	0.000564	0.000703	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—MET—kidney cancer	0.000552	0.000688	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—RAF1—kidney cancer	0.000551	0.000687	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—ERBB2—kidney cancer	0.000545	0.00068	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—KDR—kidney cancer	0.000544	0.000678	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—KDR—kidney cancer	0.000539	0.000673	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—MET—kidney cancer	0.000532	0.000664	CbGpPWpGaD
Phenazopyridine—Hypersensitivity—Doxorubicin—kidney cancer	0.000529	0.00267	CcSEcCtD
Phenazopyridine—SCN3A—Axon guidance—MET—kidney cancer	0.000528	0.000658	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—KDR—kidney cancer	0.000518	0.000646	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—KDR—kidney cancer	0.000518	0.000646	CbGpPWpGaD
Phenazopyridine—Pruritus—Doxorubicin—kidney cancer	0.000508	0.00257	CcSEcCtD
Phenazopyridine—SCN2A—Axon guidance—MET—kidney cancer	0.000507	0.000632	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—MET—kidney cancer	0.000507	0.000632	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—RAF1—kidney cancer	0.000504	0.000629	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—KDR—kidney cancer	0.0005	0.000623	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—KDR—kidney cancer	0.0005	0.000623	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—ERBB2—kidney cancer	0.000499	0.000622	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—KDR—kidney cancer	0.000498	0.00062	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Doxorubicin—kidney cancer	0.000491	0.00248	CcSEcCtD
Phenazopyridine—SCN10A—Axon guidance—MET—kidney cancer	0.000489	0.00061	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—MET—kidney cancer	0.000489	0.00061	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—MET—kidney cancer	0.000487	0.000607	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CTNNA1—kidney cancer	0.000485	0.000605	CbGpPWpGaD
Phenazopyridine—SCN5A—L1CAM interactions—MAPK3—kidney cancer	0.000484	0.000604	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—VEGFA—kidney cancer	0.000471	0.000588	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—PAX6—kidney cancer	0.000465	0.000579	CbGpPWpGaD
Phenazopyridine—SCN5A—L1CAM interactions—MAPK1—kidney cancer	0.000461	0.000575	CbGpPWpGaD
Phenazopyridine—Vomiting—Doxorubicin—kidney cancer	0.000457	0.00231	CcSEcCtD
Phenazopyridine—Rash—Doxorubicin—kidney cancer	0.000453	0.00229	CcSEcCtD
Phenazopyridine—Dermatitis—Doxorubicin—kidney cancer	0.000452	0.00228	CcSEcCtD
Phenazopyridine—Headache—Doxorubicin—kidney cancer	0.00045	0.00227	CcSEcCtD
Phenazopyridine—SCN7A—Axon guidance—MAPK3—kidney cancer	0.000446	0.000556	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—RAF1—kidney cancer	0.000441	0.00055	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—RELA—kidney cancer	0.000439	0.000548	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—ERBB2—kidney cancer	0.000437	0.000544	CbGpPWpGaD
Phenazopyridine—Nausea—Doxorubicin—kidney cancer	0.000426	0.00215	CcSEcCtD
Phenazopyridine—SCN7A—Axon guidance—MAPK1—kidney cancer	0.000424	0.000529	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—VEGFA—kidney cancer	0.00042	0.000524	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—RAF1—kidney cancer	0.000408	0.000508	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—ERBB2—kidney cancer	0.000403	0.000503	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—PAK1—kidney cancer	0.000403	0.000502	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—KDR—kidney cancer	0.000402	0.000502	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—KRAS—kidney cancer	0.000401	0.000499	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000398	0.000496	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—MAPK3—kidney cancer	0.000397	0.000495	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000395	0.000492	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MET—kidney cancer	0.000394	0.000491	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—RAF1—kidney cancer	0.000393	0.00049	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—RELA—kidney cancer	0.000392	0.000488	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—RAF1—kidney cancer	0.00039	0.000486	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—ERBB2—kidney cancer	0.000389	0.000485	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—ERBB2—kidney cancer	0.000386	0.000481	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—KDR—kidney cancer	0.000385	0.00048	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—VEGFA—kidney cancer	0.000384	0.000479	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—CTNNB1—kidney cancer	0.000382	0.000476	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—MAPK1—kidney cancer	0.000378	0.000471	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—MET—kidney cancer	0.000377	0.00047	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—RAF1—kidney cancer	0.000375	0.000467	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—RAF1—kidney cancer	0.000375	0.000467	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—ERBB2—kidney cancer	0.000371	0.000462	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—ERBB2—kidney cancer	0.000371	0.000462	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—KDR—kidney cancer	0.00037	0.000461	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—KDR—kidney cancer	0.00037	0.000461	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—MAPK3—kidney cancer	0.000363	0.000453	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MET—kidney cancer	0.000362	0.000451	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MET—kidney cancer	0.000362	0.000451	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—RAF1—kidney cancer	0.000361	0.00045	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—RAF1—kidney cancer	0.000361	0.00045	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—RAF1—kidney cancer	0.00036	0.000449	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—RELA—kidney cancer	0.000358	0.000447	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—ERBB2—kidney cancer	0.000357	0.000446	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—ERBB2—kidney cancer	0.000357	0.000446	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—KRAS—kidney cancer	0.000357	0.000445	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—KDR—kidney cancer	0.000357	0.000445	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—KDR—kidney cancer	0.000357	0.000445	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—ERBB2—kidney cancer	0.000356	0.000444	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—KDR—kidney cancer	0.000351	0.000438	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MET—kidney cancer	0.000349	0.000435	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MET—kidney cancer	0.000349	0.000435	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000347	0.000433	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—MAPK1—kidney cancer	0.000346	0.000431	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MET—kidney cancer	0.000344	0.000429	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—CTNNB1—kidney cancer	0.00034	0.000424	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—VEGFA—kidney cancer	0.000336	0.000419	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—KRAS—kidney cancer	0.000327	0.000407	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—MAPK3—kidney cancer	0.000318	0.000397	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—CTNNB1—kidney cancer	0.000311	0.000388	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—VEGFA—kidney cancer	0.000311	0.000387	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—MAPK1—kidney cancer	0.000303	0.000377	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—VEGFA—kidney cancer	0.0003	0.000374	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—VEGFA—kidney cancer	0.000297	0.000371	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—MAPK3—kidney cancer	0.000294	0.000366	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—RAF1—kidney cancer	0.000291	0.000363	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—RELA—kidney cancer	0.00029	0.000361	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—ERBB2—kidney cancer	0.000288	0.000359	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—KRAS—kidney cancer	0.000286	0.000356	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—VEGFA—kidney cancer	0.000285	0.000356	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—VEGFA—kidney cancer	0.000285	0.000356	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—MAPK3—kidney cancer	0.000284	0.000354	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—MAPK3—kidney cancer	0.000281	0.00035	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—MAPK1—kidney cancer	0.00028	0.000349	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—RAF1—kidney cancer	0.000278	0.000347	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—RELA—kidney cancer	0.000277	0.000345	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—ERBB2—kidney cancer	0.000275	0.000343	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—VEGFA—kidney cancer	0.000275	0.000343	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—VEGFA—kidney cancer	0.000275	0.000343	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—VEGFA—kidney cancer	0.000274	0.000342	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—MAPK3—kidney cancer	0.00027	0.000337	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—MAPK3—kidney cancer	0.00027	0.000337	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—MAPK1—kidney cancer	0.00027	0.000336	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—MAPK1—kidney cancer	0.000267	0.000333	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—RAF1—kidney cancer	0.000267	0.000333	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—RAF1—kidney cancer	0.000267	0.000333	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—RELA—kidney cancer	0.000266	0.000332	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—RELA—kidney cancer	0.000266	0.000332	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—ERBB2—kidney cancer	0.000265	0.00033	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—ERBB2—kidney cancer	0.000265	0.00033	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—KRAS—kidney cancer	0.000264	0.000329	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—MAPK3—kidney cancer	0.00026	0.000325	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—MAPK3—kidney cancer	0.00026	0.000325	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—MAPK3—kidney cancer	0.000259	0.000323	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—RAF1—kidney cancer	0.000258	0.000321	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—RAF1—kidney cancer	0.000258	0.000321	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—MAPK1—kidney cancer	0.000257	0.00032	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—MAPK1—kidney cancer	0.000257	0.00032	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—RELA—kidney cancer	0.000257	0.00032	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—RELA—kidney cancer	0.000257	0.00032	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—ERBB2—kidney cancer	0.000255	0.000318	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—ERBB2—kidney cancer	0.000255	0.000318	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—KRAS—kidney cancer	0.000255	0.000318	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—RAF1—kidney cancer	0.000254	0.000317	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—KRAS—kidney cancer	0.000253	0.000315	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—CTNNB1—kidney cancer	0.000252	0.000314	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—ERBB2—kidney cancer	0.000251	0.000313	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—KDR—kidney cancer	0.000251	0.000313	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—MAPK1—kidney cancer	0.000248	0.000309	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—MAPK1—kidney cancer	0.000248	0.000309	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—MAPK1—kidney cancer	0.000247	0.000308	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MET—kidney cancer	0.000245	0.000306	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—KRAS—kidney cancer	0.000243	0.000303	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—KRAS—kidney cancer	0.000243	0.000303	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—CTNNB1—kidney cancer	0.000241	0.0003	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—KRAS—kidney cancer	0.000234	0.000292	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—KRAS—kidney cancer	0.000234	0.000292	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—KRAS—kidney cancer	0.000233	0.000291	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—CTNNB1—kidney cancer	0.000231	0.000289	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—CTNNB1—kidney cancer	0.000231	0.000289	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—CTNNB1—kidney cancer	0.000223	0.000278	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—CTNNB1—kidney cancer	0.000223	0.000278	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—VEGFA—kidney cancer	0.000222	0.000276	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—VEGFA—kidney cancer	0.000212	0.000264	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MAPK3—kidney cancer	0.00021	0.000261	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—VEGFA—kidney cancer	0.000204	0.000254	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—VEGFA—kidney cancer	0.000204	0.000254	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—MAPK3—kidney cancer	0.000201	0.00025	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MAPK1—kidney cancer	0.0002	0.000249	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—VEGFA—kidney cancer	0.000196	0.000245	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—VEGFA—kidney cancer	0.000196	0.000245	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—VEGFA—kidney cancer	0.000194	0.000241	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MAPK3—kidney cancer	0.000193	0.00024	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MAPK3—kidney cancer	0.000193	0.00024	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—MAPK1—kidney cancer	0.000191	0.000238	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—KRAS—kidney cancer	0.000188	0.000235	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MAPK3—kidney cancer	0.000186	0.000232	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MAPK3—kidney cancer	0.000186	0.000232	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MAPK1—kidney cancer	0.000183	0.000229	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MAPK1—kidney cancer	0.000183	0.000229	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MAPK3—kidney cancer	0.000183	0.000228	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—RAF1—kidney cancer	0.000181	0.000226	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—RELA—kidney cancer	0.00018	0.000225	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—KRAS—kidney cancer	0.00018	0.000225	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—ERBB2—kidney cancer	0.000179	0.000224	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MAPK1—kidney cancer	0.000177	0.00022	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MAPK1—kidney cancer	0.000177	0.00022	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MAPK1—kidney cancer	0.000174	0.000217	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—KRAS—kidney cancer	0.000173	0.000216	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—KRAS—kidney cancer	0.000173	0.000216	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—KRAS—kidney cancer	0.000167	0.000208	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—KRAS—kidney cancer	0.000167	0.000208	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—KRAS—kidney cancer	0.000165	0.000205	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CTNNB1—kidney cancer	0.000157	0.000196	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—VEGFA—kidney cancer	0.000138	0.000172	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MAPK3—kidney cancer	0.000131	0.000163	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MAPK1—kidney cancer	0.000124	0.000155	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—KRAS—kidney cancer	0.000117	0.000146	CbGpPWpGaD
